Safety and Efficacy of ABI-009 (Nab-rapamycin) in Combination With Pomalidomide and Dexamethasone for Relapsed and Refractory Multiple Myeloma

NCT03657420 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding withdrawn by sponsor

Conditions

Multiple Myeloma

Interventions

DRUG: ABI-009
DRUG: Pomalidomide
DRUG: Dexamethasone

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]